Method Article
This method was developed with the goal of delivering a steady drug solution via the carotid artery, to assess the pharmacokinetics of novel drugs in mouse models.
When proposing the use of a drug, drug combination, or drug delivery into a novel system, one must assess the pharmacokinetics of the drug in the study model. As the use of mouse models are often a vital step in preclinical drug discovery and drug development1-8, it is necessary to design a system to introduce drugs into mice in a uniform, reproducible manner. Ideally, the system should permit the collection of blood samples at regular intervals over a set time course. The ability to measure drug concentrations by mass-spectrometry, has allowed investigators to follow the changes in plasma drug levels over time in individual mice1, 9, 10. In this study, paclitaxel was introduced into transgenic mice as a continuous arterial infusion over three hours, while blood samples were simultaneously taken by retro-orbital bleeds at set time points. Carotid artery infusions are a potential alternative to jugular vein infusions, when factors such as mammary tumors or other obstructions make jugular infusions impractical. Using this technique, paclitaxel concentrations in plasma and tissue achieved similar levels as compared to jugular infusion. In this tutorial, we will demonstrate how to successfully catheterize the carotid artery by preparing an optimized catheter for the individual mouse model, then show how to insert and secure the catheter into the mouse carotid artery, thread the end of the catheter out through the back of the mouse’s neck, and hook the mouse to a pump to deliver a controlled rate of drug influx. Multiple low volume retro-orbital bleeds allow for analysis of plasma drug concentrations over time.
Drug infusion through the carotid can be performed reliably and reproducibly by optimizing equipment and technique. The procedure is not intricate, although it does require fine control and attention to detail. Superior care and dexterity are needed to isolate the carotid artery and insert the catheter, which can generally be acquired through practice. Surgery by an experienced technician should not exceed one hour. After successful surgery, the mouse should appear normal and healthy (although the mouse may react to the actual drug infusion), and drug(s) may be administered in a controlled, uniform continuous dosage. Blood samples must be taken from a site other than the carotid artery; retro-orbital bleeds proved easy to collect and satisfactory for analysis of drug concentrations.
Catheters of optimum size and shape are an invaluable asset in performing a successful infusion11. We found the catheters available commercially often to be too large and/or too flexible to allow for convenient access to the mouse carotid artery. It proved preferable to fashion catheters from the polyethylene tubing used to connect the mouse to the infusion syringe. Thus, all the tubing, connectors and needles were of consistent dimensions, which simplified infusion assembly. Using this technique, it is not necessary to push the tip of the catheter into the artery past the point where it is still visible, and blood flow to the carotid artery is not restored until after the catheter is initially secured. This reduces the hazards of puncturing the artery or of having the catheter pushed out by the high pressure of blood flow. The catheter design herein does not incorporate a “bump” to hold it in place, so securing the catheter well with sutures and surgical tape is a priority.
Infusions may be preferable to the common i.v. bolus injections, as a better mimic of clinical administration of drugs such as taxanes3, 12, 13. The technique described here was originally developed to allow infusion into mouse models wherein access to the jugular or femoral vein was precluded by mammary tumor growth and/or excessive vascularization of the insertion area. This method may often be appropriate even in tumor-free mice: although isolating and catheterizing the carotid is slightly more invasive, we found it preferable to the jugular, because the propensity of the jugular wall to rip resulted in more failed insertions and failures to complete the 3 hr time course.
While the results shown here are from C57BL/6J (in-house-bred) mice, we have used this technique to successfully infuse paclitaxel into several strains of mice, including FVB and mixed-strains, to follow the pharmacokinetics in mouse models transgenically manipulated to down-regulate cellular transporter functions. The blood and tissue samples collected showed expected levels of paclitaxel, in the range of the levels seen after jugular infusions1. This technique may be expected to work equally well in other mouse models and with other infusion solutions.
This protocol has been approved by the Fox Chase Cancer Center Institutional Animal Care and Use Committee and by the Laboratory Animal Facility, and found to be in accordance with institutional guidelines for humane treatment of animals.
1. Preliminary Preparation
2. Surgery
3. Infusion
4. Sample Analysis
NOTE: All samples for this protocol were analyzed through an outside laboratory by liquid chromatography-tandem mass spectrometry (LC-MS/MS), who calculated the paclitaxel concentrations as follows:
Paclitaxel distribution follows predictable patterns during a 3 hr dosing regimen of a 15 min high-speed infusion, followed by a 165 min low-speed infusion.
Figure 1 shows a comparison of jugular vein-infusion plasma paclitaxel concentrations and carotid artery-infusions. The paclitaxel concentrations drop quickly in the first 15 min following an initial high volume infusion, and then level off over the next 150 min. By comparison, paclitaxel levels in a poor infusion start off relatively low, and hover up and down throughout the assay. This was most likely caused by a blockage in the line early in the infusion. Records of the assay show the mouse had little to no external reaction to the infusion, corroborating the idea of an inferior administration of drug. Figure 2 shows relative levels of paclitaxel in liver and brain tissue, as well as blood plasma, at the end of the 3 hr infusion.
Figure 1: Plasma paclitaxel levels during carotid and jugular infusions. Curves represent plasma paclitaxel concentrations in individual mice. Each mouse received a biphasic infusion, consisting of an initial high-speed, 15 min infusion of 0.42 mg/kg/min, immediately followed by a low-speed, 165 min infusion of 0.021mg/kg/min. The area under the curve (AUC) for carotid infusion was approximately 59 μg/ml∙min versus an AUC for jugular infusion of approximately 37 μg/ml∙min. The half-life of paclitaxel calculated from the curves generated for carotid infusion was 10 min and for jugular infusion was 11 min. Carotid infusion shows roughly equivalent levels of drug concentration compared to jugular infusion. Continuous low concentrations, or concentrations that cycle up and down, often represent a poor infusion.
Figure 2: Paclitaxel concentration by tissue. Immediately following the 3 hr paclitaxel infusion and collection of the last blood sample, the mouse was euthanized, and liver and brain tissue samples were collected. Paclitaxel concentration levels in plasma and tissues were acquired by mass-spec analysis. This data represents samples collected from the Carotid Infusion-Mouse in Figure 1.
Figure 3: Surgical paraphernalia. (A) Catheter Production: Pulling ones own catheters keeps down material expenses, while allowing the researcher to tailor size and shape of catheter to mouse age and size. (B) Prepare before Surgery: Three (3) silk sutures, approximately 8 cm each; Sterile port plug; Saline syringe and lead; Catheter, attached to heparin syringe.
Figure 4: Preparation of carotid artery and catheter insertion. (A) Cut through skin, move aside glands and use forceps to grossly separate fat to expose muscle. (B) Use forceps to gently separate muscle to expose right side of trachea. Carotid artery will become visible as largest, thick-walled vessels, running parallel to trachea. (C) Break fascia around artery. (D) Separate vagus nerve from carotid artery. (E) Continue removing fascia until carotid is completely isolated along cavity. (F) Suture permanent knot at anterior extremity, and slip knot at posterior extremity. (G) Third suture is threaded under carotid and very loosely knotted. (H) Artery is nicked just above anterior suture. (I) Insert catheter into nick in artery. Grab anterior suture with forceps to pull artery down over catheter. (J) Secure catheter in carotid artery with all three sutures.
Figure 5: Suture placement. Schematic representation of surgical site before and after catheter installation. A corresponds with photograph Figure 4G, with the addition of a nick in the artery, as in Figure 4H. B corresponds with photograph Figure 4J.
Figure 6: Schematic of infusion set-up. Syringe is filled with drug, and capped with a blunt needle. Polyethylene line attaches syringe to carotid catheter. Pump slowly compresses syringe, to deliver uniform dosage directly into the bloodstream.
Carotid artery infusion is a significant technique in this study of paclitaxel pharmacokinetics. Carotid artery infusion is a method to quickly distribute drug throughout the circulatory system14. The 3 hr infusion is a closer mimic of clinical administration of drugs such as taxanes than bolus injections. The surgery can be reliably performed by a single individual, surgery time is relatively short, and success rates are >75%. After samples are collected, they must be analyzed by the appropriate methods. We used mass spectrometry to determine the paclitaxel concentration in plasma and tissue samples. To further validate this technique, we sent blood and tissue samples to an independent lab for analysis. This data was plotted as individual plasma-paclitaxel concentration curves for each animal tested (Figure 1), and the distribution of paclitaxel was compared in different tissues (Figure 2). In each case, it is important to consider the best method to analyze drug distribution and/or metabolism, depending on the drug and system of interest. Other options for measurement of different drugs may include HPLC-UV or immunoassays 2.
Two primary factors essential for successful carotid catheterization are well fashioned catheters and superior artery isolation. Fashioning catheters according to the size of the mouse model is paramount. If the catheter diameter is too thick, insertion into the artery will be overly difficult, while a too thin catheter will be harder to secure and likely to clog before or during infusion. The angle and sharpness of the catheter tip must also be in a moderate range; a tip that is too sharp may puncture the artery wall, while a tip that is too dull will be difficult to insert into the artery. The measurements given here were derived using ten-week-old C57BL/6J mice, approximately 20 g, as a model template. Measurements must be scaled up or down empirically to fit individual models.
Isolation of the carotid artery must be a delicate, deliberate process to avoid needless damage to tissue and to prevent large-scale bleeding. Subcutaneous-fat can generally be easily separated with low to medium sharp forceps. Muscle tissue over the carotid should be separated with medium to fine tipped forceps along the bias of the muscle fibers. If a more extensive gap is necessary, the technician must be extremely careful to avoid rupturing small blood vessels. Once the carotid is visible, there will still be a fair amount of fascia that needs to be tweezed away from the artery with fine tipped forceps. Finally, the vagus nerve must be separated from the carotid artery without damage to either. When the carotid is properly isolated, it should be possible to insert the forceps underneath, with an empty space on either side of the artery (see Figure 4E).
When trouble shooting poor infusions, start by reviewing the instructions on the pump to be sure that the investigator has properly programmed the pump to deliver the expected dosage. Then, carefully consider changing the volume that will be introducing into the test animal. The dilution of drug must be calculated so that the dosage volume is appropriate: the volume must not be too large for the animal to tolerate, and ideally will not significantly affect blood pressure; yet the volume must be large enough for the pump to deliver reliably, and will create a steady flow to avoid clogs at junctions. If clogs become a regular occurrence, consider switching to a smaller gauge (larger diameter) needle and tubing. Further, if plasma drug content does not reach expected levels, the researcher should check the mice post mortem to determine whether the catheter remains well placed in the artery and free-flowing, and modify the shape/size of catheter as necessary.
The usefulness of this method may be limited by such factors as the size and general health of the subject, and the intended length of time of the infusion. The surgery and infusion can overtax an already distressed subject. Even in a healthy animal, carotid artery catheter is only appropriate for short term infusions, generally several hours to several days. Consider what methods of pain-relief will be used if mice show signs of discomfort in response to the drug infusion, such as repeated applications of topical anesthesia to wound sites, or pre-emptive systemic analgesics. It will be necessary to have all animal work approved by the local animal regulatory organization or IACUC, to obtain the appropriate permissions to perform this procedure. If it is necessary to have a longer infusion, or to have the mouse survive the infusion for an extended period of time, alternative infusion methods must be explored.
After having mastered carotid artery perfusions in the study of the pharmacokinetics of paclitaxel, we plan to use this technique in the future to investigate the effects of other drugs, and Abcc10 modulators in the C57BL/6J and FVB mice, and other mouse models.
The authors have nothing to disclose.
We would like to acknowledge the FCCC Laboratory Animal Facility for their support in this project. We thank Wolfe Laboratories, Inc. for their assistance in analyzing paclitaxel levels in plasma and tissue. This work was supported by National Institutes of Health grants K01CA120091 to E.H.B., and CA06927 to Fox Chase Cancer Center.
Name | Company | Catalog Number | Comments |
Polyethylene tubing 0.024” OD X 0.011” ID | Braintree Scientific, Inc. | PE10 | |
3 Blunted needles (30 gauge) | Braintree Scientific, Inc. | NB-30 | |
Stainless steel port plug (28 gauge) | Braintree Scientific, Inc. | PP-28 | Slightly larger than PE tubing ID, to fit snugly and keep a tight seal. |
2 Stainless steel connector plugs (30 gauge) | Braintree Scientific, Inc. | C-30 | |
Three 1 cc syringes | Becton, Dickinson and Co. | 309659 | |
Sterile 0.9% Saline solution | Hospira | 0409-7984-37 | |
Cath-Loc HGS Heparin/Glycerol Solution | Braintree Scientific, Inc. | HGS | |
Silk suture | Braintree Scientific, Inc. | SUT-S 113 | |
Vanna Scissors (micro-scissors) | World Precision Instruments | 14122 | This model has a curved tip, but straight-tip scissors work as well. |
Hartman Mesquito Hemostatic Forceps | World Precision Instruments | 501705 | |
Betadine Swabsticks | Perdue Products L.P. | BSWS1S | |
Bupivacaine | Hospira | 0409-1160-01 | May be replaced with Lidocaine, or similar local anesthesia. |
Paclitaxel | LC Laboratories | P-9600 | |
Methanol | Sigma-Aldrich | 32213 | |
Micro-Hematocrit Capillary Tubes, Heparinized | Fisher Scientific | 22-362-566 | |
Micro Capillary Tube Sealant | Fisher Scientific | 02-678 | |
C57BL/6J mice | Fox Chase Cancer Center, Laboratory Animal Facility in-house-bred | ||
API 4000 Q-Trap mass spetrometer | Applied Biosystems |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved